Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9817)
All Articles published online
|
Publishing Process of This Article
|
Dec 21, 2013 (publication date) through Feb 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lee CH, Kim JH, Lee SW. Prospects for nucleic acid-based therapeutics against hepatitis C virus. World J Gastroenterol 2013; 19(47): 8949-8962 [PMID: 24379620 DOI: 10.3748/wjg.v19.i47.8949] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i47/8949.htm |
| Number | Citing Articles |
| 1 |
Hirofumi Morihara, Tsuyoshi Yamamoto, Harunori Oiwa, Kota Tonegawa, Daisuke Tsuchiyama, Ikki Kawakatsu, Masanori Obana, Makiko Maeda, Tomomi Mohri, Satoshi Obika, Yasushi Fujio, Hiroyuki Nakayama. Phospholamban Inhibition by a Single Dose of Locked Nucleic Acid Antisense Oligonucleotide Improves Cardiac Contractility in Pressure Overload-Induced Systolic Dysfunction in Mice. Journal of Cardiovascular Pharmacology and Therapeutics 2017; 22(3): 273 doi: 10.1177/1074248416676392
|
| 2 |
Tae-Hyeong Kim, Seong-Wook Lee. Aptamers for Anti-Viral Therapeutics and Diagnostics. International Journal of Molecular Sciences 2021; 22(8): 4168 doi: 10.3390/ijms22084168
|
| 3 |
Patrick Arbuthnot. Gene Therapy for Viral Infections. 2015; : 191 doi: 10.1016/B978-0-12-410518-8.00007-7
|
| 4 |
Stefan Mockenhaupt, Stefanie Grosse, Daniel Rupp, Ralf Bartenschlager, Dirk Grimm. Alleviation of off-target effects from vector-encoded shRNAs via codelivered RNA decoys. Proceedings of the National Academy of Sciences 2015; 112(30) doi: 10.1073/pnas.1510476112
|
| 5 |
Alba Fernández-Sanlés, Beatriz Berzal-Herranz, Rodrigo González-Matamala, Pablo Ríos-Marco, Cristina Romero-López, Alfredo Berzal-Herranz. RNA Aptamers as Molecular Tools to Study the Functionality of the Hepatitis C Virus CRE Region. Molecules 2015; 20(9): 16030 doi: 10.3390/molecules200916030
|
| 6 |
E. Crouchet, R. Saad, C. Affolter-Zbaraszczuk, J. Ogier, T. F. Baumert, C. Schuster, F. Meyer. Composite vector formulation for multiple siRNA delivery as a host targeting antiviral in a cell culture model of hepatitis C virus (HCV) infection. Journal of Materials Chemistry B 2017; 5(4): 858 doi: 10.1039/C6TB01718E
|
| 7 |
Anandita Agarwala, Peter Jones, Vijay Nambi. The Role of Antisense Oligonucleotide Therapy in Patients with Familial Hypercholesterolemia: Risks, Benefits, and Management Recommendations. Current Atherosclerosis Reports 2015; 17(1) doi: 10.1007/s11883-014-0467-4
|
| 8 |
Chang Ho Lee, Seung Ryul Han, Seong-Wook Lee. Therapeutic Applications of Aptamer-Based Riboswitches. Nucleic Acid Therapeutics 2016; 26(1): 44 doi: 10.1089/nat.2015.0570
|
| 9 |
Tejabhiram Yadavalli, Ipsita Volety, Deepak Shukla. Aptamers in Virology—A Consolidated Review of the Most Recent Advancements in Diagnosis and Therapy. Pharmaceutics 2021; 13(10): 1646 doi: 10.3390/pharmaceutics13101646
|
| 10 |
Chang Ho Lee, Ji Hyun Kim, Seong-Wook Lee. The role of microRNAs in Hepatitis C Virus replication and related liver diseases. Journal of Microbiology 2014; 52(6): 445 doi: 10.1007/s12275-014-4267-x
|
| 11 |
Peng Li, Bow Ho, Jeak Ling Ding. Future Perspectives on New Approaches in Pathogen Detection. Biomedical Science Letters 2015; 21(4): 165 doi: 10.15616/BSL.2015.21.4.165
|
| 12 |
Víctor González, M. Martín, Gerónimo Fernández, Ana García-Sacristán. Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses. Pharmaceuticals 2016; 9(4): 78 doi: 10.3390/ph9040078
|
| 13 |
Kei Xian Tan, Sharadwata Pan, Jaison Jeevanandam, Michael K. Danquah. Cardiovascular therapies utilizing targeted delivery of nanomedicines and aptamers. International Journal of Pharmaceutics 2019; 558: 413 doi: 10.1016/j.ijpharm.2019.01.023
|